? Eculizumab, complement inhibitor in severe COVID19

from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts.com

? Eculizumab, complement inhibitor in severe COVID19 | Dr RR Baliga's 'Got Knowledge Doc?' Podkasts for Physicians | Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? | Circulation https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.120.047419#.XqjUc7YNhYU.twitter Not Medical Advice or Opinion

Episode metadata supplied by the publisher feed · Published Apr 29, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

? Eculizumab, complement inhibitor in severe COVID19

0:00 8:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr RR Baliga's "Got Knowledge Doc" Podkast?

This episode is 8 minutes long.

When was this Dr RR Baliga's "Got Knowledge Doc" Podkast episode published?

This episode was published on April 29, 2020.

Can I download this Dr RR Baliga's "Got Knowledge Doc" Podkast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!